What does Zentalis Pharmaceuticals, Inc. (ZNTL) do?

Zentalis Pharmaceuticals, Inc. (ZNTL) is a publicly traded company.

What sector does ZNTL operate in?

Zentalis Pharmaceuticals, Inc. operates in the equity market. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find ZNTL earnings analysis?

AlphaOS publishes an earnings intelligence page for Zentalis Pharmaceuticals, Inc. (ZNTL) covering results, guidance context, and AI-assisted analysis. See /stocks/ZNTL/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 55%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

ZNTL

Zentalis Pharmaceuticals, Inc.

$2.87Sep 23, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Zentalis Pharmaceuticals, Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Pipeline evidence · 0d ago

ZNTL's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on ZNTL.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q4 2025

Full ZNTL earnings analysis

Reported figures for Zentalis Pharmaceuticals, Inc. — research only, not investment advice.

Revenue YoY: -100.0%

Latest Intelligence

Updated September 30, 2026

What happened recently for Zentalis Pharmaceuticals, Inc. (ZNTL) — events, not interpretation.

Event: Reported Q4 2025 revenue -100% YoY.
Also: Last session September 23, 2026 at $2.87.
Source: Q4 2025 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Zentalis Pharmaceuticals, Inc. (ZNTL)

US equity research on AlphaOS

Investment Snapshot above is the primary AlphaOS analysis for Zentalis Pharmaceuticals, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Market cap:: $205.70M
Revenue:: $0

ZNTL earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Zentalis Pharmaceuticals, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.